Evaluation of response and survival of patients with head and neck squamous cell carcinoma submitted to surgical resection as exclusive therapy at the Clinical Hospital of the State University of Campinas
Main Authors: | Daniel Naves Araujo Teixeira, Fabio Lau, Vanessa Carvalho de Oliveira, Eduardo Vieira Couto, Lígia Traldi Macedo, Carmen Silvia Passos Lima, Carlos Takahiro Chone |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-11-01
|
Series: | Brazilian Journal of Otorhinolaryngology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1808869422001471 |
Similar Items
-
Association of Clinical Aspects and Genetic Variants with the Severity of Cisplatin-Induced Ototoxicity in Head and Neck Squamous Cell Carcinoma: A Prospective Cohort Study
by: Ligia Traldi Macedo, et al.
Published: (2023-03-01) -
Genetic variability in cisplatin metabolic pathways and outcome of locally advanced head and neck squamous cell carcinoma patients
by: Ana Maria Castro Ferreira, et al.
Published: (2023-10-01) -
Time to reflect on diversity, equity, and inclusion in otolaryngology head and neck surgery academic setting
by: Carlos Takahiro Chone
Published: (2023-09-01) -
Prognosis of Midkine and AT1R expression in resectable head and neck squamous cell carcinoma
by: Tai-Jan Chiu, et al.
Published: (2023-09-01) -
Rational sequence of monoclonal antibodies in the treatment of non-resectable head and neck squamous cell carcinoma
by: L. V. Bolotina, et al.
Published: (2022-04-01)